Clinical Trials Browser

Phase 2 × Recurrence × Endocrine × Clear all

Recurrence, Neuroendocrine Tumors

NCT04889742 2023-12-26

HETERERO

EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

NCT01413503 2018-09-18

A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors

Phase 2 Completed

50 enrolled 7 charts

CNSEndocrine

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

NCT00786552 2011-01-20

Panthera

Phase 2 Unknown

47 enrolled

EndocrineHead & Neck

Recurrence, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Clinical Trials

Entinostat Neuroendocrine (NE) Tumor

HETERERO

A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors

Panthera